Symptoms suggesting high blood pressure: Severe headaches, chest pain, shortness of breath, or visual changes
Compounded options (not FDA-approved): Compounded Semaglutide - injectable, once weekly Compounded Tirzepatide - injectable, once weekly Compounded Oral Semaglutide - once-daily dissolving tablet Compounded Oral Tirzepatide - once-daily dissolving tablet Brand-name options (FDA-approved for their indicated uses): Ozempic - brand-name semaglutide
patents keep generics out until around 2031 or 2035, maintaining Novo Nordisks exclusivity and high prices Bookmark CommentsGo to comments Affordable, regulated versions of Ozempic, the well-known diabetes and weight-loss shot from Novo Nordisk, are about to hit markets around the world, which could shake up the obesity drug scene
The primary concern with air bubbles is dosing accuracy rather than safety
As the active ingredient in Wegovy and other GLP-1 medications, semaglutide triggers changes inside your body that help you finally lose excess weight